organ rejection

Talaris pulls off $150M IPO to tackle organ rejection, autoimmune disorders
Fierce Biotech
Fri, 05/7/21 - 10:50 am
IPOs
Talaris Therapeutics
organ rejection
Veloxis wins $1.3B buyout deal, and the new owner plans to follow up with new deals
Endpoints
Tue, 11/26/19 - 09:47 am
Asahi Kasei
Veloxis Pharmaceuticals
M&A
organ rejection
Envarsus XR
kidney transplants